Haploinsufficiency of the brain-derived neurotrophic factor gene is associated with reduced pain sensitivity
Rare pain-insensitive individuals offer unique insights into how pain circuits function and have led to the development of new strategies for pain control. We investigated pain sensitivity in humans with WAGR (Wilms tumor, aniridia, genitourinary anomaly, and range of intellectual disabilities) synd...
Saved in:
Published in | Pain (Amsterdam) Vol. 160; no. 5; pp. 1070 - 1081 |
---|---|
Main Authors | , , , , , , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
United States
Wolters Kluwer
01.05.2019
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | Rare pain-insensitive individuals offer unique insights into how pain circuits function and have led to the development of new strategies for pain control. We investigated pain sensitivity in humans with WAGR (Wilms tumor, aniridia, genitourinary anomaly, and range of intellectual disabilities) syndrome, who have variably sized heterozygous deletion of the 11p13 region. The deletion region can be inclusive or exclusive of the brain-derived neurotrophic factor (
BDNF
) gene, a crucial trophic factor for nociceptive afferents. Nociceptive responses assessed by quantitative sensory testing demonstrated reduced pain sensitivity only in the WAGR subjects whose deletion boundaries included the
BDNF
gene. Corresponding behavioral assessments were made in heterozygous
Bdnf
knockout rats to examine the specific role of
Bdnf
. These analogous experiments revealed impairment of Aδ- and C-fiber-mediated heat nociception, determined by acute nociceptive thermal stimuli, and in aversive behaviors evoked when the rats were placed on a hot plate. Similar results were obtained for C-fiber-mediated cold responses and cold avoidance on a cold-plate device. Together, these results suggested a blunted responsiveness to aversive stimuli. Our parallel observations in humans and rats show that hemizygous deletion of the
BDNF
gene reduces pain sensitivity and establishes BDNF as a determinant of nociceptive sensitivity. |
---|---|
Bibliography: | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 These authors contributed equally to this manuscript Author Contributions M.R.S. designed experiments, performed behavioral testing and RNA-Seq analyses on animals, performed statistics, constructed figures, and analyzed and interpreted the data. D.M.L. analyzed the data, constructed figures, and extracted RNA. T.L. performed and interpreted nerve conduction measurements for human subjects. A.E.T. performed and interpreted cognitive testing in human subjects, and assisted in designing and interpreting the pain assessments for human subjects. K.M.D. S.R.F. M.D.L. A.E.H. directly performed or supervised research assistants in pain testing of human subject. S.J.S. and J.W.T. performed and interpreted neurological examinations on human subjects. M.J.I. analyzed the data, supervised behavioral assessments. J.C.H. designed human pain testing methods adapted for visual impairment, performed statistics, and analyzed the human subject data. M.J.I., J.A.Y., A.J.M., and J.C.H supervised the overall project and management. M.J.I., J.A.Y., and J.C.H. conceived the project. M.R.S., M.J.I., and J.C.H. prepared the manuscript. |
ISSN: | 0304-3959 1872-6623 1872-6623 |
DOI: | 10.1097/j.pain.0000000000001485 |